Thermo Fisher Scientific Inc · NYSE:TMO
Thermo Fisher Scientific — Merger or Acquisition (May 2016)
12 slides from Thermo Fisher Scientific's merger presentation, May 27, 2016
Slide 1: Acquisition of FEI Company
May 27, 2016 Acquisition of FEI Company Exhibit 99.2
Slide 2: Safe Harbor Statement / Use of Non-GAAP Financial Measures
Safe Harbor Statement / Use of Non-GAAP Financial Measures The following constitutes a “Safe Harbor” statement under the Private Securities Litigation Reform Act of 1995: This communication contains forward-looking statements that involve a number of risks and uncertainties. Important factors that c
Slide 3: Additional Information Regarding the Transaction
In connection with the transaction, FEI intends to file relevant materials with the Securities and Exchange Commission (the “SEC”), including a preliminary proxy statement on Schedule 14A. Promptly after filing its definitive proxy statement with the SEC, FEI will mail the definitive proxy statement
Slide 4: Acquisition of FEI – Creating Value for Our Shareholders
Acquisition of FEI – Creating Value for Our Shareholders FEI – the leader in high-performance electron microscopy Outstanding strategic fit with Thermo Fisher Scientific and strengthens our Analytical Instruments offering Net purchase price of $4.2B to be funded with cash and new debt Financially co
Slide 5: FEI Overview
Services & Software 29% Instrument Systems 71% Product Portfolio* Revenue by Geography* North America 32% Europe 27% 41% APAC & ROW FEI Overview Leader in high-performance electron microscopy Leading technology portfolio serving life sciences and materials science markets 2015 revenue of $930 millio
Slide 6: Outstanding Strategic Fit
Outstanding Strategic Fit Life Sciences Solutions 25% Specialty Diagnostics 19% Analytical Instruments 18% Laboratory Products and Services 38% $17.3B Revenue Thermo Fisher Scientific Reporting Segments Today Analytical Instruments Segment with FEI NOTE: Thermo Fisher Scientific revenue and segment
Slide 7: Strategic Rationale for Acquisition of FEI
Strategic Rationale for Acquisition of FEI Enhances Thermo Fisher Scientific’s unique customer value proposition Leading electron microscopy platform complements mass spectrometry leadership to accelerate advancements in structural biology Combined technology portfolio creates new opportunities in a
Slide 8: Offering Industry-Leading Products, Software and Services
Offering Industry-Leading Products, Software and Services Life Sciences Materials Science Services High resolution analysis in structural biology and cellular and tissue biology for academic and biopharma customers Supports academic and industrial customers’ R&D in metals, physical chemistry and new
Slide 9: Highly Complementary Technologies
Highly Complementary Technologies Leading mass spectrometry protein analysis and quantitation Innovative protein structural analysis Broad molecular and elemental analysis portfolio Sub-nm SEM imaging Life Sciences Materials Science Opportunity Capitalize on growth in structural biology market Furth
Slide 10: Compelling Financial Profile
Compelling Financial Profile Price Total net cash consideration of $4.2 billion $107.50 per fully diluted share Assumes FEI has $400 million net cash at close Returns Attractive return profile and accretive to adjusted EPS Expected to add $0.30 to adjusted EPS in first full year after close Synergie
Slide 11: Transaction Overview
Transaction Overview Financing Fully committed bridge facility in place Permanent financing from available cash and issuance of new debt Leverage Pro forma leverage ratio expected to be approximately 3.6x at close Our strong free cash flow will allow for rapid repayment of debt Path to Completion FE
Slide 12: Acquisition of FEI – Creating Value for Our Shareholders
Acquisition of FEI – Creating Value for Our Shareholders FEI – the leader in high-performance electron microscopy Outstanding strategic fit with Thermo Fisher Scientific and strengthens our Analytical Instruments offering Net purchase price of $4.2B to be funded with cash and new debt Financially co
Thermo Fisher Scientific — Merger or Acquisition (May 2016) on 6ix